IP Library Granted Patent US 11,596,618
Granted Patent B2
US 11,596,618 · App. 17/150,418 · Granted Mar 7, 2023

Oral cannabinoid delivery formulations with mouthfeel experience enhancers

Inventors: Eric Greenbaum (Minneapolis, MN); Emily Leuer (Minneapolis, MN); Nikolaus Goran (Minneapolis, MN); Justin Bueno (Minneapolis, MN)
Assignee: Resurgent Biosciences, Inc.
A61K31/352A61K9/0056A61K9/1075A61K31/05A61K45/06A61K47/10A61K47/36A61K47/46A61K47/549A61K47/6951
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,596,618
App. No.
17/150,418
Granted
Mar 7, 2023
Kind
B2
Abstract

Oral formulations comprising at least one cannabinoid and at least one mouthfeel experience enhancer are described. For example, methods and materials for preparing a dissolvable lozenge comprising a combination of THC and CBD and Szechuan peppercorn or an extract thereof are provided.

Claims (4)

1. An oral formulation comprising at least one cannabinoid and at least one mouthfeel experience enhancer, wherein the at least one mouthfeel enhancer comprises a tingling agent selected from the group consisting of Japanese pepper extract, Szechuan peppercorn or an extract thereof, sanshool-I, sanshool-II, hydroxy-alpha-sanshool, and sanshoamide, and wherein the oral formulation is a hard candy lozenge formulated to undergo a slow and uniform dissolution or erosion over 5-10 minutes, without disintegration, and wherein the formulation does not include a soft candy composition, wherein the lozenge comprises a core and an outer layer, wherein the core comprises tetrahydrocannabinol and cannabidiol and the outer layer comprises Szechuan peppercorn or an extract thereof.

2. An oral formulation comprising at least one cannabinoid and at least one mouthfeel experience enhancer, wherein the at least one mouthfeel enhancer comprises a tingling agent selected from the group consisting of Japanese pepper extract, Szechuan peppercorn or an extract thereof, sanshool-I, sanshool-II, hydroxy-alpha-sanshool, and sanshoamide, and wherein the oral formulation is a hard candy lozenge formulated to undergo a slow and uniform dissolution or erosion over 5-10 minutes, without disintegration, and wherein the formulation does not include a soft candy composition, wherein the lozenge comprises an intermediate layer disposed between a core and an outer layer, wherein the core comprises a first cannabinoid and Szechuan peppercorn or an extract thereof and a second mouthfeel experience enhancer, the intermediate layer comprises a second cannabinoid and a third mouthfeel experience enhancer, and the outer layer comprises at least a third cannabinoid.

3. The oral formulation of claim 2 , wherein the second and the third mouthfeel experience enhancers are independently selected from the group consisting of a warming agent, tingling agent, cooling agent, puckering agent and sialagogue.

4. The oral formulation of claim 2 , wherein the first, the second and the third cannabinoids are independently selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabigerol, cannabichromene, tetrahydrocannabivarin, and combinations thereof.

Assignments (4)
SECURITY INTEREST Recorded Jul 15, 2025
From: VIREO HEALTH, INC.; VIREO HEALTH OF MINNESOTA, LLC; WHOLESOMECO, INC.; DEEP ROOTS HARVEST, INC.; DEEP ROOTS ARIA ACQCO, INC.; RESURGENT BIOSCIENCES, INC.; NEW GROWTH HORIZON, LLC
To: CHICAGO ATLANTIC ADMIN, LLC
Reel/Frame 071709/0176 →
SECURITY INTEREST Recorded Jul 8, 2025
From: RESURGENT BIOSCIENCES, INC.; DEEP ROOTS HARVEST, INC.; DEEP ROOTS ARIA ACQCO, INC.; VIREO HEALTH, INC.; VIREO HEALTH OF MINNESOTA, LLC; WHOLESOMECO, INC.; NEW GROWTH HORIZON, LLC
To: EAST WEST BANK
Reel/Frame 071841/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: GREENBAUM, ERIC; LEUER, EMILY; GORAN, NIKOLAUS; BUENO, JUSTIN
To: RESURGENT BIOSCIENCES, INC
Reel/Frame 062392/0493 →
SECURITY INTEREST Recorded Mar 25, 2021
From: VIREO HEALTH INTERNATIONAL, INC.
To: CHICAGO ATLANTIC ADMIN, LLC
Reel/Frame 055721/0544 →
Continuity (2)
Provisional Application 62961539 · Jan 15, 2020
Related Publication 20210212983A1 · Jul 15, 2021